共 50 条
PREDICTION OF LOW DISEASE ACTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH SECUKINUMAB IN REAL WORLD - DATA FROM THE GERMAN AQUILA STUDY
被引:0
|作者:
Vodencarevic, A.
[1
]
Brandt-Juergens, J.
[2
]
Peterlik, D.
[1
]
Gmeiner, B.
[1
]
Kiltz, U.
[3
]
机构:
[1] Novartis Pharma GmbH, Novartis, Nurnberg, Germany
[2] Schwerpunktpraxis, Rheumatol, Berlin, Germany
[3] Herne & Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany
关键词:
Real-world evidence;
Spondyloarthritis;
Artificial Intelligence;
D O I:
10.1136/annrheumdis-2023-eular.229
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
OP0058
引用
收藏
页码:38 / 38
页数:1
相关论文